ALDH1A3 levels are significantly higher in ICB non-responders. scRNA-seq data from approximately 14, 200 malignant cells from Pozniak et al., 202448were interrogated for ALDH1A3 expression and early response to ICB. ∗∗∗∗p< 0.0001, Wilcoxon signed-rank test.
